Immune checkpoint inhibitor combination therapies very frequently induce secondary adrenal insufficiency

Immune checkpoint inhibitors (ICIs) are potent therapeutic options for many types of advanced cancer. The expansion of ICIs use however has led to an increase in immune-related adverse events (irAEs). Secondary adrenal insufficiency (AI) can be life-threatening especially in patients with delayed di...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Sci Rep
Main Authors: Manaka, Katsunori, Sato, Junichiro, Takeuchi, Maki, Watanabe, Kousuke, Kage, Hidenori, Kawai, Taketo, Sato, Yusuke, Miyagawa, Takuya, Yamada, Daisuke, Kume, Haruki, Sato, Shinichi, Nagase, Takahide, Iiri, Taroh, Nangaku, Masaomi, Makita, Noriko
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8172846/
https://ncbi.nlm.nih.gov/pubmed/34078988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-91032-6
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares